Results 101 to 110 of about 12,135 (165)
No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine.
Artemether-lumefantrine is a new fixed antimalarial combination effective against multidrug-resistant falciparum malaria. A prospective electrocardiographic study was conducted in 150 patients receiving artemetherlumefantrine and 50 treated with ...
F Nosten +13 more
core +1 more source
PHARMACOKINETICS OF LUMEFANTRINE IN HEALTHY PAKISTANI VOLUNTEERS
Objective: To study the pharmacokinetics of lumefantrine in healthy Pakistani volunteers so as to see the adequacy of the regimen in vogue for the treatment of malaria and prevention of recrudescence.
Nusrat Jafery, Muzammil Hassan Najmi
doaj +2 more sources
AIM: Drug-drug interactions between antimalarial and antiretroviral drugs may influence antimalarial treatment outcomes. The aim of this study was to investigate the potential drug-drug interactions between the anti-malarial drugs; lumefantrine ...
Pauline Byakika‐Kibwika +18 more
core +1 more source
Background As Ethiopia is one of the sub-Saharan countries with a great burden of malaria the effectiveness of first line anti-malarial drugs is the major concern.
Mohammed Biset Ayalew
doaj +1 more source
Introduction Despite advances in clinical care, therapeutic strategies, and governmental interventions, malaria remains a significant public health concern—particularly in Africa, which consistently ranks highest in global morbidity and mortality ...
Gloria Bujo Dhimbe +4 more
doaj +1 more source
Background Artemether-lumefantrine is one of the most widely used anti-malarial drug combinations in the world with excellent tolerability and cure rates in adult and paediatric patients with uncomplicated falciparum malaria. The aim of this study was to
Tarning Joel +3 more
doaj +1 more source
Correlation of capillary and venous plasma concentration of lumefantrine in children at 2, 24, 120hr post last dose of artemether-lumefantrine.
Richard Kajubi (5638430) +6 more
core +1 more source
Artemether‐lumefantrine for uncomplicated malaria: a systematic review
BACKGROUND The World Health Organization (WHO) is promoting artemether-lumefantrine for treating uncomplicated malaria. The objective of this review is to summarize available evidence of its effects compared with other antimalarial regimens.METHODS We ...
Aika A. Omari +5 more
core +1 more source
Appolinary AR Kamuhabwa,1 Richard Silumbe21Unit of Pharmacology and Therapeutics, School of Pharmacy, Muhimbili University of Health and Allied Sciences, 2Pharmacy Council, Dar es Salaam, TanzaniaBackground: Irrational prescribing and dispensing of ...
Kamuhabwa AA, Silumbe R
doaj
Artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria
Stephan Ehrhardt, Christian G MeyerBernhard Nocht Institute for Tropical Medicine, Tropical Medicine Section, Hamburg, GermanyAbstract: The World Health Organization strongly recommends artemisinin-based combination therapy (ACT) regimens for the ...
Stephan Ehrhardt, Christian G Meyer
doaj

